MEMBER REPORT

ANNUAL IMPACT

TABLE OF CONTENTS

Letter to Members 1Capital + Growth 2Education + Networking 3Policy + Advocacy 4Workforce Cultivation 5Member Savings 6Our Members 7The Colorado Advantage 8Board Members 9

DEAR CBSA MEMBERS + SUPPORTERS,

Colorado BioScience Association is proud to lead the way with co-opportunity. That’s our commitment to build a collaborative, pro-innovation environment for life sciences in Colorado. From concept to commercialization, our 350 members drive health innovations that save and change lives around the world. CBSA champions these big thinkers and bold leaders at all stages of growth. We are proud to support a thriving life sciences ecosystem that includes 720 companies and organizations representing biotechnology, pharmaceutical, medical device, diagnostics, ag bio-animal health, digital health, research and academic institutions, and service providers. CBSA prioritizes investments in four areas to advance our community: Capital + GrowthPolicy + AdvocacyEducation + NetworkingWorkforce Cultivation Our annual impact report highlights the momentum we continue to generate for our ecosystem and the progress we’ve made. We are energized and focused as we accelerate growth of Colorado’s life sciences ecosystem and grateful for your support and commitment to collaboration. On behalf of our board of directors and team, thank you.

Stronger Together,

Jennifer Jones PatonPresident & CEOColorado BioScience Association

Membership Report A N N U A L I M PA C T 1

Capital + Growth

220 Attendees

30 Presenting Companies from the Rocky Mountain Region

44 Investors from Across the United States

Membership Report A N N U A L I M PA C T 2

Accelerating our ecosystem’s success with increased access to capital.

INVESTOR ENGAGEMENT

CBSA leads the biannual Rocky Mountain Life Sciences Investor and Partnering Conference, attracting VCs, strategic partners and angel investors from across the country.

HIGH-PROFILE FINANCINGS

$805 Million $11.4 Billion

Raised by Colorado Companies

Acquisition of Array BioPharma by Pfizer

ANNUAL AWARDS DINNER Celebrates Ecosystem Success

2 019 COMPAN Y OF THE Y E AR

2 019 R IS ING STAR OF THE Y E AR

2 019 DE AL OF THE Y E AR

Array BioPharma Acquisition by Pfizer

Membership Report A N N U A L I M PA C T 3

Creating opportunities for collaboration and professional growth.

30 programs and events held across Colorado’s Front Range attracted 1,300 attendees.

Education + Networking

Working for a supportive, innovation-friendly business environment.

FEDERAL SUCCESS

CBSA led Colorado efforts on full repeal of the medical device excise tax in 2019.

STATE FOCUS

CBSA advocates for language, amendments and legislation that support our innovation ecosystem.

COLORADO IMPACT: ADVANCED INDUSTRIES GRANTS

CBSA protects and grows the Advanced Industries Accelerator Grant Program, a critical source of non-dilutive funding for life sciences companies.

Since inception, the state Office of Economic Development and International Trade (OEDIT) has awarded more than 450 Advanced Industries grants to Colorado bioscience companies. Results:

Policy + Advocacy

81 new companies

975 direct jobs

$972 Million in follow-on grants & investments

Advanced Industries Accelerator Grant Program Results

Membership Report A N N U A L I M PA C T 4

Membership Report A N N U A L I M PA C T 5

Connecting companies to jobseekers and building an educated, skilled talent pool.

CBSA’s newly redesigned career center is the state’s most comprehensive resource for life sciences jobs.

CBSA works alongside Colorado BioScience Institute (the Institute) to cultivate a strong life sciences talent pipeline in Colorado.

Workforce Cultivation

“Seven years after graduating from the Colorado BioScience Institute Executive Leadership Program, my company and I are still realizing tremendous value from the leadership skills developed, the relationships built and the community served.” — Elyse Blazevich Co-Founder, COO and CFO Securisyn Medical

Workforce Development and Training

• P-TECH, STEM Education and teacher training • Mentoring and internships• Connecting talent and employers • Workforce skill building• Leadership development

Offering members strength in numbers with negotiated discounts.

CBSA offers a significant return on membership through our member savings program. We develop state, regional and national partnerships to offer exclusives discounts for companies of all sizes, from lab equipment to office supplies and insurance.

Participating companies saved more than:

$4.2 million.

Member Savings

“CBSA has been one of my best business partners with the connections to suppliers and business development opportunities. Active engagement with CBSA drives ROI.”

— Amy Wedeking Shannon Chief Commercial Officer Prima-Temp

Membership Report A N N U A L I M PA C T 6

Membership Report A N N U A L I M PA C T 7

CBSA members drive global health innovations,

products and services that improve and save lives, from concept to

commercialization.

Biotech/Pharma

Medical Device/Diagnostic

Digital Health

Ag Bio-Animal Health

52%

34%

8%4%

Our Members

More than 100 service provider members advance our life sciences ecosystem

An exceptional place to start, grow, commercialize or relocate a life sciences business.

33 federal labs

1 U.S. Patent Office

#1 Place for female entrepreneurs

#3 Place to do business

#4 Venture capital deals and dollars

#4 Most educated state

#5 Busiest airport

The Colorado Advantage

Membership Report A N N U A L I M PA C T 8

Scott Larson (Board Chair) Senior Vice President, Legal and General Counsel, Terumo BCT

Alan Rudolph, Ph.D. (Board Secretary) Vice President, Research, Colorado State University

Bob Reddy (Board Chair-Elect) Vice President, Global Marketing, Medical Education and Training, Medtronic Enabling Technologies

Kathleen (Kiki) Traylor, M.D. (Board Vice-Chair Elect) Director, State Government Affairs, Amgen

Jim Wilson (Board Treasurer) Partner, Ernst & Young

Larry Blankenship (Executive Committee) Director, Blankenship Research

Jim Cloar (Executive Committee) President, Zimmer Biomet Spine

Bobbi Coffin (Executive Committee) Chief Marketing Officer, Biodesix

Dustin Whistler (Executive Committee) Principal, Forte Commercial Real Estate

Dan Wittenberg (Executive Committee) Partner, Snell & Wilmer, LLP

Shelley Zelin (Executive Committee) A Xcellent HR Solution

Elyse Blazevich Co-Founder/Chief Operating Officer/Chief Financial Officer, Securisyn Medical

Gary Connell Co-President, Shareholder, Sheridan Ross

Terry Dagnon Chief Operating Officer/Managing Director Healthcare Investment Management, Outlook Therapeutics/GMS Capital

Gino DiSciullo, Ph.D. CEO, Prevacept Infection Control/Charter Life Sciences

Bruce Eaton, Ph.D. President & CEO, i2 Pharmaceuticals & Velocity Sciences

Brent Fassett Partner, Cooley, LLP

April Giles Vice President, Business Development, Fitzsimons Innovation Community

Joseph Guiles, Ph.D. Head of Development, Agilent Technologies, Inc.

Charlie Kang Consultant, Flatirons Bio-Consulting

Mark Lupa, Ph.D. Partner, High Country Venture

Ethan Mann, Ph.D. Vice President of Marketing/Sales, Sharklet Technologies, Inc.

Bryn Rees Assistant Vice Chancellor, Research & Innovation Managing Director, Ventures Partners of CU Boulder

Andy Sklawer Co-Founder and Chief Operating Officer, Brickell Bio

Fintan Steele Chief Corporate Communications and Culture Officer, SomaLogic

Will Vaughan, Ph.D. Director, Technology Transfer, Colorado School of Mines

Steve Warnecke Chairman and Chief Executive Officer, Evolutionary Genomics

Michael Weiner Partner, Dorsey & Whitney, LLP

Our Board of Directors

Membership Report A N N U A L I M PA C T 9

Our Sponsors

colorado-bioscience-association

@cobioscience

ColoradoBioScienceAssociation

cobioscience.com